Articles for Dechra Pharmaceuticals (LSE: DPH)

GlaxoSmithKline plc isn’t the only pharma stock I’d buy today

Royston Wild explains why GlaxoSmithKline plc (LON: GSK) isn't the only pharma star that could make you a fortune. More »

Does Halma plc’s double-digit growth make it the steal of the century?

Halma plc (LON: HLMA) has seen its earnings soar, and here's another that's done even better. More »

2 top pharma stocks I’d buy right now

These two pharma stocks could offer long-term growth potential. More »

Looking to invest £2,000? Here are 2 pharma stocks I’d buy today

Harvey Jones says these two pharmaceutical stocks have something to please both momentum and contrarian investors. More »

2 pharma stocks I’d buy in March

G A Chester discusses two stocks he'd buy in the under-performing pharmaceuticals sector. More »

2 no-brainer stocks I’d buy in pharma

Royston Wild reveals two pharma stocks with the capability to deliver knockout profits growth. More »

2 opportunities to beat the FTSE 100 which won’t last forever

These two stocks could help you to generate higher returns than the FTSE 100 (INDEXFTSE:UKX). More »

2 pharma stocks that could make you a millionaire

The FTSE 100 isn’t the last word for great pharmaceutical stocks. Here, Royston Wild looks at two medical marvels outside of the blue-chip index. More »

A growth-plus-dividend stock I’d buy ahead of Vodafone Group plc

Vodafone Group plc (LON:VOD) offers big dividends, but here's a smaller stock that could be a better buy. More »

2 stocks that could make you rich

Bilaal Mohamed identifies two London-listed firms with spectacular growth potential. More »

This FTSE 250 dog might be a stonking contrarian pick

Today's trading update suggests investors are being far too negative on this FTSE 250 (INDEXFTSE:MCX) stock. More »

2 surprising growth stocks that could help you retire early

These two shares may offer higher growth rates than expected. More »

These great growth stocks have much further to go

Royston Wild looks at two stocks with hot earnings prospects. More »

One growth stock I’d buy — and one I’d sell — right now

Royston Wild discusses two growth stocks with very different near-term outlooks. More »

Enjoy double-digit earnings growth with these FTSE 250 stars

Royston Wild looks at three FTSE 250 (INDEXFTSE: MCX) stocks with spectacular earnings potential. More »

Why I’m avoiding these exciting growth shares right now

Bilaal Mohamed explains why investors should wait before buying these growth stocks. More »

Should you make room for Pets At Home Group plc after today’s update?

The market may not like today's update but Paul Summers thinks Pets At Home Group plc (LON:PETS) is a sound defensive play. More »

Does this pharma’s 56% sales growth make it a better buy than GlaxoSmithKline plc?

Should you sell GlaxoSmithKline plc (LON: GSK) and pile into this hot pharma stock? More »

4 growth stocks to put on your 2017 shopping list

Royston Wild runs the rule over some of London’s hottest growth stocks. More »

Could these top-performing stocks be about to collapse?

Bilaal Mohamed considers whether these shares are heading for a correction after this year's spectacular gains. More »